NASDAQ: CBIOCrescent Biopharma Inc Stock Ownership - Who owns Crescent Biopharma?
Insider buying vs selling
Have Crescent Biopharma Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when CBIO insiders and whales buy or sell their stock.
CBIO Shareholders
What type of owners hold Crescent Biopharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Scott D. Sandell | 101.18% | 14,056,571 | $195.39M | Insider |
| M. James Barrett | 94.89% | 13,182,418 | $183.24M | Insider |
| Peter J. Barris | 94.89% | 13,182,418 | $183.24M | Insider |
| Siren LLC | 61.82% | 8,589,064 | $119.39M | Insider |
| Invus Public Equities LP | 45.47% | 6,317,565 | $87.81M | Insider |
| New Enterprise Associates 10 L P | 35.96% | 4,995,664 | $69.44M | Insider |
| New Enterprise Associates 13 LP | 29.46% | 4,093,377 | $56.90M | Insider |
| Fairmount Funds Management LLC | 9.99% | 1,387,866 | $19.29M | Insider |
| Sanofi | 8.59% | 1,193,625 | $16.59M | Insider |
| Michael A. Henos | 7.16% | 995,395 | $13.84M | Insider |
CBIO vs Biotech Stocks
Crescent Biopharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.